Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Intragastric Balloon Placement Induces Significant Metabolic and Histologic Improvement in Patients With Nonalcoholic Steatohepatitis
Fateh Bazerbachi, Eric J. Vargas, Monika Rizk, et al.
Clinical Gastroenterology and Hepatology (2020) Vol. 19, Iss. 1, pp. 146-154.e4
Open Access | Times Cited: 100

Showing 1-25 of 100 citing articles:

American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings
Kenneth Cusi, Scott Isaacs, Diana Barb, et al.
Endocrine Practice (2022) Vol. 28, Iss. 5, pp. 528-562
Open Access | Times Cited: 669
Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
Kuei‐Chuan Lee, Pei-Shan Wu, Han‐Chieh Lin
Clinical and Molecular Hepatology (2022) Vol. 29, Iss. 1, pp. 77-98
Open Access | Times Cited: 113
Healthcare and socioeconomic costs of NAFLD: A global framework to navigate the uncertainties
Alina M. Allen, Jeffrey V. Lazarus, Zobair M. Younossi
Journal of Hepatology (2023) Vol. 79, Iss. 1, pp. 209-217
Open Access | Times Cited: 86
Antifibrotic therapy in nonalcoholic steatohepatitis: time for a human-centric approach
Paul Brennan, Ahmed M. Elsharkawy, Timothy J. Kendall, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 10, pp. 679-688
Open Access | Times Cited: 50
The effect of the magnitude of weight loss on non-alcoholic fatty liver disease: A systematic review and meta-analysis
Dimitrios A. Koutoukidis, Constantinos Koshiaris, John A. Henry, et al.
Metabolism (2020) Vol. 115, pp. 154455-154455
Open Access | Times Cited: 104
Preparing for the NASH Epidemic: A Call to Action
Fasiha Kanwal, Jay H. Shubrook, Zobair M. Younossi, et al.
Gastroenterology (2021) Vol. 161, Iss. 3, pp. 1030-1042.e8
Open Access | Times Cited: 81
Aktualisierte S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – April 2022 – AWMF-Registernummer: 021–025
Elke Roeb, Ali Canbay, Frank Tacke, et al.
Zeitschrift für Gastroenterologie (2022) Vol. 60, Iss. 09, pp. 1346-1421
Open Access | Times Cited: 53
Indian National Association for Study of the Liver (INASL) Guidance Paper on Nomenclature, Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease (NAFLD)
Ajay Duseja, Shivaram Prasad Singh, Arka De, et al.
Journal of Clinical and Experimental Hepatology (2022) Vol. 13, Iss. 2, pp. 273-302
Open Access | Times Cited: 53
AGA Clinical Practice Update on Bariatric Surgery in Cirrhosis: Expert Review
Heather Patton, Julie K. Heimbach, Arthur J. McCullough
Clinical Gastroenterology and Hepatology (2020) Vol. 19, Iss. 3, pp. 436-445
Open Access | Times Cited: 62
European guideline on obesity care in patients with gastrointestinal and liver diseases – Joint ESPEN/UEG guideline
Stephan C. Bischoff, Rocco Barazzoni, Luca Busetto, et al.
Clinical Nutrition (2022) Vol. 41, Iss. 10, pp. 2364-2405
Open Access | Times Cited: 38
European guideline on obesity care in patients with gastrointestinal and liver diseases – Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guideline
Stephan C. Bischoff, Rocco Barazzoni, Luca Busetto, et al.
United European Gastroenterology Journal (2022) Vol. 10, Iss. 7, pp. 663-720
Open Access | Times Cited: 38
Nonalcoholic Fatty Liver Disease: Review of Management for Primary Care Providers
Rita Basu, Mazen Noureddin, Jeanne M. Clark
Mayo Clinic Proceedings (2022) Vol. 97, Iss. 9, pp. 1700-1716
Open Access | Times Cited: 34
Treatment Options and Continuity of Care in Metabolic-associated Fatty Liver Disease: A Multidisciplinary Approach
Carmen Lara, Manuel Romero‐Gómez
European Cardiology Review (2024) Vol. 19
Open Access | Times Cited: 7
Role of the Intestine and Its Gut Microbiota in Metabolic Syndrome and Obesity
Celine B.E. Busch, Jacques Bergman, Max Nieuwdorp, et al.
The American Journal of Gastroenterology (2024) Vol. 119, Iss. 6, pp. 1038-1046
Closed Access | Times Cited: 6
Preparing for the NASH Epidemic: A Call to Action
Fasiha Kanwal, Jay H. Shubrook, Zobair M. Younossi, et al.
Diabetes Care (2021) Vol. 44, Iss. 9, pp. 2162-2172
Open Access | Times Cited: 40
Efficacy and Safety of Intragastric Balloon (IGB) in Non-alcoholic Fatty Liver Disease (NAFLD): a Comprehensive Review and Meta-analysis
Saurabh Chandan, Babu P. Mohan, Shahab R. Khan, et al.
Obesity Surgery (2021) Vol. 31, Iss. 3, pp. 1271-1279
Closed Access | Times Cited: 35
Preparing for the NASH epidemic: A call to action
Fasiha Kanwal, Jay H. Shubrook, Zobair M. Younossi, et al.
Metabolism (2021) Vol. 122, pp. 154822-154822
Open Access | Times Cited: 35
Brazilian evidence-based guideline for screening, diagnosis, treatment, and follow-up of metabolic dysfunction-associated steatotic liver disease (MASLD) in adult individuals with overweight or obesity: A joint position statement from the Brazilian Society of Endocrinology and Metabolism (SBEM), Brazilian Society of Hepatology (SBH), and Brazilian Association for the Study of Obesity and Metabolic Syndrome (Abeso)
Rodrigo O. Moreira, Cynthia Melissa Valério, Cristiane Alves Villela‐Nogueira, et al.
Archives of Endocrinology and Metabolism (2023) Vol. 67, Iss. 6
Open Access | Times Cited: 13
Adjustable intragastric balloon for treatment of obesity: a multicentre, open-label, randomised clinical trial
Barham K. Abu Dayyeh, Daniel B. Maselli, Babusai Rapaka, et al.
The Lancet (2021) Vol. 398, Iss. 10315, pp. 1965-1973
Closed Access | Times Cited: 31
AGA Technical Review on Intragastric Balloons in the Management of Obesity
Raj Shah, Perica Davitkov, Barham K. Abu Dayyeh, et al.
Gastroenterology (2021) Vol. 160, Iss. 5, pp. 1811-1830
Open Access | Times Cited: 29
Obesity Management in the Primary Prevention of Hepatocellular Carcinoma
Elizabeth R. M. Zunica, Elizabeth C. Heintz, Christopher L. Axelrod, et al.
Cancers (2022) Vol. 14, Iss. 16, pp. 4051-4051
Open Access | Times Cited: 21
Updated S2k Clinical Practice Guideline on Non-alcoholic Fatty Liver Disease (NAFLD) issued by the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS) – April 2022 – AWMF Registration No.: 021–025

Zeitschrift für Gastroenterologie (2022) Vol. 60, Iss. 09, pp. e733-e801
Open Access | Times Cited: 21
Nonalcoholic fatty liver disease from a primary care perspective
Jeanne M. Clark, Donna R. Cryer, Michelle Morton, et al.
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 6, pp. 1421-1433
Open Access | Times Cited: 13
Research Priorities for Precision Medicine in NAFLD
Paula Iruzubieta, Ramón Bataller, M. Arias, et al.
Clinics in Liver Disease (2023) Vol. 27, Iss. 2, pp. 535-551
Open Access | Times Cited: 12
Liver fat as risk factor of hepatic and cardiometabolic diseases
Münevver Demir, Stefan R. Bornstein, Christos S. Mantzoros, et al.
Obesity Reviews (2023) Vol. 24, Iss. 10
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top